We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRSNW icon
13701
NeuroSense Therapeutics Warrant
NRSNW
$1.85K ﹤0.01%
11,588
-26,346
-69% -$4.8K
FEXDR
13702
DELISTED
Fintech Ecosystem Development Corp. Right
FEXDR
$1.85K ﹤0.01%
13,212
-394
-3% -$51
IZRL icon
13703
PUT
ARK Israel Innovative Technology ETF
IZRL
$141M
$1.85K ﹤0.01%
+100
New +$1.91K
OPA.WS
13704
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$1.84K ﹤0.01%
46,690
-995
-2% -$44
BLUA.WS
13705
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$1.84K ﹤0.01%
38,081
-25,439
-40% -$1.44K
TOON icon
13706
PUT
Kartoon Studios
TOON
$37.4M
$1.83K ﹤0.01%
1,310
-19,210
-94% -$34.2K
WE
13707
DELISTED
WeWork Inc.
WE
$1.83K ﹤0.01%
607
+380
+167% +$2.61K
BRKL
13708
PUT
DELISTED
Brookline Bancorp
BRKL
$1.82K ﹤0.01%
200
-6,200
-97% -$59.9K
KELYA icon
13709
PUT
Kelly Services Class A
KELYA
$558M
$1.82K ﹤0.01%
100
-2,800
-97% -$50.5K
ENFY
13710
PUT
DELISTED
Enlightify Inc
ENFY
$1.81K ﹤0.01%
800
+200
+33% +$490
NSLR
13711
PUT
Neostellar Capital Corp
NSLR
$278M
$1.81K ﹤0.01%
500
-2,600
-84% -$9.64K
NKTX icon
13712
PUT
Nkarta
NKTX
$167M
$1.81K ﹤0.01%
1,300
-6,900
-84% -$13.1K
GRTX
13713
PUT
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.79K ﹤0.01%
10,200
-12,500
-55% -$15.5K
TNYA icon
13714
PUT
Tenaya Therapeutics
TNYA
$163M
$1.78K ﹤0.01%
700
-4,500
-87% -$18.8K
ZH
13715
Zhihu
ZH
$273M
$1.78K ﹤0.01%
285
-4,268
-94% -$27.9K
PSTX
13716
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1.77K ﹤0.01%
746
-87,319
-99% -$183K
BTTX
13717
CALL
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$1.77K ﹤0.01%
+4,600
New +$3.1K
HYMC icon
13718
PUT
Hycroft Mining Holding Corp
HYMC
$2.52B
$1.76K ﹤0.01%
590
-1,100
-65% -$4.07K
AROW icon
13719
PUT
Arrow Financial
AROW
$727M
$1.75K ﹤0.01%
+103
New +$1.9K
LFWD icon
13720
CALL
ReWalk Robotics
LFWD
$21M
$1.75K ﹤0.01%
+27
New +$1.65K
REAX icon
13721
CALL
Real Brokerage
REAX
$523M
$1.74K ﹤0.01%
1,200
+1,100
+1,100% +$1.92K
PLSE icon
13722
Pulse Biosciences
PLSE
$3.18B
$1.74K ﹤0.01%
+431
New +$2.68K
LENZ
13723
CALL
LENZ Therapeutics
LENZ
$149M
$1.74K ﹤0.01%
100
-414
-81% -$7.2K
ARAV
13724
PUT
DELISTED
Aravive, Inc. Common Stock
ARAV
$1.73K ﹤0.01%
+13,100
New +$8.23K
PPBT
13725
PUT
Purple Biotech
PPBT
$2.44M
$1.73K ﹤0.01%
8
-10
-56% -$2.38K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.